Search by Drug Name or NDC
NDC 16837-0855-09 PEPCID AC 20 mg/1 Details
PEPCID AC 20 mg/1
PEPCID AC is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Johnson & Johnson Consumer Inc.. The primary component is FAMOTIDINE.
MedlinePlus Drug Summary
Prescription famotidine is used to treat ulcers (sores on the lining of the stomach or small intestine); gastroesophageal reflux disease (GERD, a condition in which backward flow of acid from the stomach causes heartburn and injury of the esophagus [tube that connects the mouth and stomach]); and conditions where the stomach produces too much acid, such as Zollinger-Ellison syndrome (tumors in the pancreas or small intestine that cause increased production of stomach acid). Over-the-counter famotidine is used to prevent and treat heartburn due to acid indigestion and sour stomach caused by eating or drinking certain foods or drinks. Famotidine is in a class of medications called H2 blockers. It works by decreasing the amount of acid made in the stomach.
Related Packages: 16837-0855-09Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Famotidine
Product Information
| NDC | 16837-0855 |
|---|---|
| Product ID | 16837-855_0be66c2c-b737-116a-e063-6394a90ab851 |
| Associated GPIs | 49200030000320 |
| GCN Sequence Number | 011677 |
| GCN Sequence Number Description | famotidine TABLET 20 MG ORAL |
| HIC3 | Z2D |
| HIC3 Description | HISTAMINE H2-RECEPTOR INHIBITORS |
| GCN | 46430 |
| HICL Sequence Number | 004521 |
| HICL Sequence Number Description | FAMOTIDINE |
| Brand/Generic | Brand |
| Proprietary Name | PEPCID AC |
| Proprietary Name Suffix | Maximum Strength |
| Non-Proprietary Name | Famotidine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/1 |
| Substance Name | FAMOTIDINE |
| Labeler Name | Johnson & Johnson Consumer Inc. |
| Pharmaceutical Class | Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020325 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 16837-0855-09 (16837085509)
| NDC Package Code | 16837-855-09 |
|---|---|
| Billing NDC | 16837085509 |
| Package | 1 BOTTLE, PLASTIC in 1 PACKAGE (16837-855-09) / 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC |
| Marketing Start Date | 2003-09-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |